Browse Drug Recalls
17,874 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 17,874 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 17,874 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 15, 2021 | Pantoprazole Sodium Delayed-Release Tablets, USP 20 mg* 90 Tablets Rx Only ND... | CGMP Deviations: Intermittent exposure to temperature excursion during storage. | Class II | Cardinal Health Inc. |
| Mar 15, 2021 | COREG CR (carvedilol phosphate) Extended Release Capsules, 80 mg, 30-count bo... | CGMP Deviations: Intermittent exposure to temperature excursion during storage. | Class II | Cardinal Health Inc. |
| Mar 15, 2021 | Namzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10... | CGMP Deviations: Intermittent exposure to temperature excursion during storage. | Class II | Cardinal Health Inc. |
| Mar 11, 2021 | Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only,... | Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown i... | Class II | Breckenridge Pharmaceutical, Inc |
| Mar 11, 2021 | Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial pac... | Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may res... | Class II | Sagent Pharmaceuticals Inc |
| Mar 11, 2021 | ZOMA-Jet 10 Demonstration Kit, Needle-free delivery device for use with ZOMAC... | Defective Delivery System: customer complaints concerning the injector pen breaking apart and dis... | Class II | Ferring Pharmaceuticals Inc |
| Mar 11, 2021 | ZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACT... | Defective Delivery System: customer complaints concerning the injector pen breaking apart and dis... | Class II | Ferring Pharmaceuticals Inc |
| Mar 10, 2021 | Durisan Antimicrobial Solutions (benzalkonium chloride) Hand Sanitizing Wipes... | Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of th... | Class I | Sanit Technologies, LLC dba Durisan |
| Mar 10, 2021 | heal the world, moisturizing original hand sanitizer, Non-Sterile Solution, A... | Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking wate... | Class I | PNHC, LLC. |
| Mar 10, 2021 | CHINA-GEL WHITE (Camphor 3.00%, Menthol 5.00%), A TOPICAL PAIN RELIEVER, pack... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | Durisan Antimicrobial Solutions (benzalkonium chloride) Hand Sanitizer, liste... | CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the sa... | Class II | Sanit Technologies, LLC dba Durisan |
| Mar 10, 2021 | CHINA_GEL (Camphor 3.00%, Menthol 5.00%) A TOPICAL PAIN RELIEVER, packaged as... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | aulief (Organic Camphor 3.00% Organic Menthol 5.00%), topical pain relief, pa... | CGMP deviations: Product being recalled as it was made in the same facility where contamination w... | Class II | China Gel Inc |
| Mar 10, 2021 | Durisan Antimicrobial Solutions (benzalkonium chloride) Hand Sanitizing Wipes... | CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the sa... | Class II | Sanit Technologies, LLC dba Durisan |
| Mar 10, 2021 | Durisan Antimicrobial Solutions (benzalkonium chloride) Hand Sanitizer, liste... | Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of th... | Class I | Sanit Technologies, LLC dba Durisan |
| Mar 9, 2021 | Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe ... | Temperature Abuse | Class III | Cardinal Health Inc. |
| Mar 9, 2021 | 0.9% SODIUM CHLORIDE Irrigation, USP 1000 mL Semi-Rigid Bottle, Rx only, Manu... | Presence of particulate matter.one confirmed customer report of particulate matter within two se... | Class II | ICU Medical Inc |
| Mar 8, 2021 | Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose... | Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed ... | Class II | Akorn, Inc. |
| Mar 4, 2021 | Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Phar... | Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities... | Class III | Teva Pharmaceuticals USA |
| Mar 2, 2021 | Acetaminophen, Extra Strength, Aspirin Free, 500 MG Tablets, 100-count bottle... | Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 co... | Class I | A-S Medication Solutions LLC. |
| Mar 2, 2021 | Nortriptyline HCL capsules, 10 mg, packaged in 30-count bottles, Rx only, Pac... | cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently tak... | Class II | Direct Rx |
| Mar 2, 2021 | Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vial... | Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP | Class III | Ferring Pharmaceuticals Inc |
| Feb 26, 2021 | Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Di... | Failed Dissolution Specifications: Out-of-specification results observed for dissolution during s... | Class II | Dr. Reddy's Laboratories, Inc. |
| Feb 26, 2021 | Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each contain... | Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low) | Class II | Alvogen, Inc |
| Feb 22, 2021 | Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouche... | Subpotent | Class III | SUN PHARMACEUTICAL INDUSTRIES INC |
| Feb 19, 2021 | Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx... | Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosi... | Class III | Jubilant Cadista Pharmaceuticals, Inc. |
| Feb 19, 2021 | Atorvastatin Calcium Tablets, 40mg, packaged in a) 90-count bottles, NDC 5511... | Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and... | Class III | Dr. Reddy's Laboratories, Inc. |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system) Delivers 30 mg over 9 hours (3.... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours (1... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system), Delivers 10 mg over 9 hours (1... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 19, 2021 | Daytrana (methylphenidate transdermal system) Delivers 20 mg over 9 hours (2.... | Defective Delivery System: Out of specification for mechanical peel. | Class II | Noven Pharmaceuticals Inc |
| Feb 18, 2021 | Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For In... | Crystallization: customer complaints for crystallization in finished product. | Class I | Zydus Pharmaceuticals (USA) Inc |
| Feb 18, 2021 | Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For I... | Crystallization: customer complaints for crystallization in finished product. | Class I | Zydus Pharmaceuticals (USA) Inc |
| Feb 17, 2021 | Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-3... | Failed Dissolution Specifications | Class II | Dr. Reddy's Laboratories, Inc. |
| Feb 17, 2021 | Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solut... | Lack of Assurance of Sterility | Class II | The General Hospital Corporation |
| Feb 17, 2021 | Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Pres... | Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rath... | Class III | Edge Pharma, LLC |
| Feb 15, 2021 | Adam's Secret Extra Strength 1500, 800 mg, 10 count blister packs, Distribute... | Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and ... | Class I | Adams.Secret.co |
| Feb 15, 2021 | Adam's Secret Extra Strength 3000, 840 mg, 10 count blister packs, Distribute... | Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and ... | Class I | Adams.Secret.co |
| Feb 15, 2021 | Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials,... | Chemical contamination; Unknown brown residue adhering to the inside of one vial. | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Epoprostenol Sodium for Injection, 1.5 mg/vial (1,500,000 ng), 10 mL vial, Rx... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial NDC ... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Sterile Diluent for Epoprostenol Sodium for Injection, 50 mL vial (NDC 0703-9... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Desmopressin Acetate Injection USP, 4 mcg/mL, 1 mL Preserved Vial (NDC 0703-5... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Dacarbazine for Injection USP, 200 mg, Single Use Vial (NDC 0703-5075-01), pa... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Vecuronium Bromide for Injection, 10 mg, 1 mg/mL when reconstituted to 10 mL,... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | MethyIPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL, 1 mL Single... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | MethyIPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, 1 mL Single-D... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Toposar (etoposide injection USP), 1 gram/50 mL (20 mg/mL), 50 mL Multiple-do... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | Epoprostenol Sodium for Injection, 0.5 mg/vial (500,000 ng), 1X10ML vial, Rx... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
| Feb 10, 2021 | MethyIPREDNISolone Acetate Injectable Suspension USP, 400 mg/5 mL (80 mg/mL),... | Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance... | Class II | Teva Pharmaceuticals USA |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.